285 related articles for article (PubMed ID: 18334579)
1. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.
Huang Y; de Morrée A; van Remoortere A; Bushby K; Frants RR; den Dunnen JT; van der Maarel SM
Hum Mol Genet; 2008 Jun; 17(12):1855-66. PubMed ID: 18334579
[TBL] [Abstract][Full Text] [Related]
2. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.
Huang Y; Laval SH; van Remoortere A; Baudier J; Benaud C; Anderson LV; Straub V; Deelder A; Frants RR; den Dunnen JT; Bushby K; van der Maarel SM
FASEB J; 2007 Mar; 21(3):732-42. PubMed ID: 17185750
[TBL] [Abstract][Full Text] [Related]
3. Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release.
Zacharias U; Purfürst B; Schöwel V; Morano I; Spuler S; Haase H
J Muscle Res Cell Motil; 2011 Dec; 32(4-5):271-80. PubMed ID: 22057634
[TBL] [Abstract][Full Text] [Related]
4. Reverse engineering gene network identifies new dysferlin-interacting proteins.
Cacciottolo M; Belcastro V; Laval S; Bushby K; di Bernardo D; Nigro V
J Biol Chem; 2011 Feb; 286(7):5404-13. PubMed ID: 21119217
[TBL] [Abstract][Full Text] [Related]
5. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
[TBL] [Abstract][Full Text] [Related]
6. A muscle-specific calpain, CAPN3, forms a homotrimer.
Hata S; Doi N; Shinkai-Ouchi F; Ono Y
Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140411. PubMed ID: 32200007
[TBL] [Abstract][Full Text] [Related]
7. Novel Missense CAPN3 Mutation Responsible for Adult-Onset Limb Girdle Muscular Dystrophy with Calves Hypertrophy.
Rekik S; Sakka S; Ben Romdhan S; Farhat N; Baba Amer Y; Lehkim L; Authier FJ; Mhiri C
J Mol Neurosci; 2019 Dec; 69(4):563-569. PubMed ID: 31410652
[TBL] [Abstract][Full Text] [Related]
8. Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles.
Ojima K; Ono Y; Ottenheijm C; Hata S; Suzuki H; Granzier H; Sorimachi H
J Mol Biol; 2011 Apr; 407(3):439-49. PubMed ID: 21295580
[TBL] [Abstract][Full Text] [Related]
9. Impaired regeneration in calpain-3 null muscle is associated with perturbations in mTORC1 signaling and defective mitochondrial biogenesis.
Yalvac ME; Amornvit J; Braganza C; Chen L; Hussain SA; Shontz KM; Montgomery CL; Flanigan KM; Lewis S; Sahenk Z
Skelet Muscle; 2017 Dec; 7(1):27. PubMed ID: 29241457
[TBL] [Abstract][Full Text] [Related]
10. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).
Anderson LV; Harrison RM; Pogue R; Vafiadaki E; Pollitt C; Davison K; Moss JA; Keers S; Pyle A; Shaw PJ; Mahjneh I; Argov Z; Greenberg CR; Wrogemann K; Bertorini T; Goebel HH; Beckmann JS; Bashir R; Bushby KM
Neuromuscul Disord; 2000 Dec; 10(8):553-9. PubMed ID: 11053681
[TBL] [Abstract][Full Text] [Related]
11. Muscle-specific calpain-3 is phosphorylated in its unique insertion region for enrichment in a myofibril fraction.
Ojima K; Ono Y; Hata S; Noguchi S; Nishino I; Sorimachi H
Genes Cells; 2014 Nov; 19(11):830-41. PubMed ID: 25252031
[TBL] [Abstract][Full Text] [Related]
12. Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch.
Waddell LB; Lemckert FA; Zheng XF; Tran J; Evesson FJ; Hawkes JM; Lek A; Street NE; Lin P; Clarke NF; Landstrom AP; Ackerman MJ; Weisleder N; Ma J; North KN; Cooper ST
J Neuropathol Exp Neurol; 2011 Apr; 70(4):302-13. PubMed ID: 21412170
[TBL] [Abstract][Full Text] [Related]
13. PLEIAD/SIMC1/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1.
Ono Y; Iemura S; Novak SM; Doi N; Kitamura F; Natsume T; Gregorio CC; Sorimachi H
J Mol Biol; 2013 Aug; 425(16):2955-72. PubMed ID: 23707407
[TBL] [Abstract][Full Text] [Related]
14. Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.
Beckmann JS; Spencer M
Neuromuscul Disord; 2008 Dec; 18(12):913-21. PubMed ID: 18974005
[TBL] [Abstract][Full Text] [Related]
15. Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation.
Pathak P; Sharma MC; Sarkar C; Jha P; Suri V; Mohd H; Singh S; Bhatia R; Gulati S
Neurol India; 2010; 58(4):549-54. PubMed ID: 20739790
[TBL] [Abstract][Full Text] [Related]
16. CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy.
Charton K; Sarparanta J; Vihola A; Milic A; Jonson PH; Suel L; Luque H; Boumela I; Richard I; Udd B
Hum Mol Genet; 2015 Jul; 24(13):3718-31. PubMed ID: 25877298
[TBL] [Abstract][Full Text] [Related]
17. A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy.
Vissing J; Barresi R; Witting N; Van Ghelue M; Gammelgaard L; Bindoff LA; Straub V; Lochmüller H; Hudson J; Wahl CM; Arnardottir S; Dahlbom K; Jonsrud C; Duno M
Brain; 2016 Aug; 139(Pt 8):2154-63. PubMed ID: 27259757
[TBL] [Abstract][Full Text] [Related]
18. Identification of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice.
Cohen N; Kudryashova E; Kramerova I; Anderson LV; Beckmann JS; Bushby K; Spencer MJ
Proteomics; 2006 Nov; 6(22):6075-84. PubMed ID: 17051641
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2A.
Charlton R; Henderson M; Richards J; Hudson J; Straub V; Bushby K; Barresi R
Neuromuscul Disord; 2009 Jul; 19(7):449-57. PubMed ID: 19556129
[TBL] [Abstract][Full Text] [Related]
20. Impaired calcium calmodulin kinase signaling and muscle adaptation response in the absence of calpain 3.
Kramerova I; Kudryashova E; Ermolova N; Saenz A; Jaka O; López de Munain A; Spencer MJ
Hum Mol Genet; 2012 Jul; 21(14):3193-204. PubMed ID: 22505582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
